Xu, Feng
Novozymes Biotech, Inc.,
United States
2025 Rank: 90066
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 350 out of 66225 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 90066 | 105191 |
| Total Cites | 304 | 309 |
| H-index | 10 | 10 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 45 | 45 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 78 | 78 |
| Number of Single+First+Last Authored Papers | 42 | 42 |
| Total Cites to Single+First+Last Authored Papers | 140 | 140 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 223 | 225 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.37 |
| Self-Citation Percentage |
1.62%
|
|
Xu, Feng
Ministry of Education of the People's Republic of China,
China
2024 Rank: 1860
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biomedical Engineering
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 7 out of 66541 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1860 | 2016 |
| Total Cites | 4313 | 4529 |
| H-index | 30 | 30 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 64 | 64 |
| Number of Single+First Authored Papers | 82 | 82 |
| Total Cites to Single+First Authored Papers | 338 | 347 |
| Number of Single+First+Last Authored Papers | 350 | 350 |
| Total Cites to Single+First+Last Authored Papers | 2346 | 2450 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3670 | 3768 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.20 |
| Self-Citation Percentage |
4.77%
|
|
Xu, Feng
Novozymes Biotech, Inc.,
United States
2023 Rank: 62845
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 240 out of 59267 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62845 | 73649 |
| Total Cites | 364 | 374 |
| H-index | 11 | 11 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 46 | 46 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 109 | 109 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 159 | 159 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 280 | 284 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.32 |
| Self-Citation Percentage |
2.67%
|
|
Xu, Feng
Novozymes Biotech, Inc.,
United States
2022 Rank: 57092
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 204 out of 56174 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57092 | 66755 |
| Total Cites | 389 | 413 |
| H-index | 12 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 51 | 51 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 105 | 105 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 155 | 155 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 280 | 289 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.43 |
| Self-Citation Percentage |
5.81%
|
|
Xu, Feng
Novozymes Biotech, Inc.,
United States
2021 Rank: 56580
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 196 out of 52513 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56580 | 66703 |
| Total Cites | 622 | 642 |
| H-index | 14 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 70 | 70 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 147 | 147 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 252 | 252 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 443 | 449 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.43 |
| Self-Citation Percentage |
3.12%
|
|
Xu, Feng
Novozymes Biotech, Inc.,
United States
2020 Rank: 40165
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biotechnology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 141 out of 50343 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40165 | 47374 |
| Total Cites | 516 | 527 |
| H-index | 13 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 72 | 72 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 147 | 148 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 227 | 228 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 359 | 363 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.45 |
| Self-Citation Percentage |
2.09%
|
|
Related Profiles
Featured Profiles
Partner with Us
📢 Reach a targeted audience of science enthusiasts and professionals through our platform. Contact our marketing team:
business@topscinet.com cc: top2percentscientist@gmail.comGet a custom proposal tailored to your banner ad goals.
Partner with Us
📢 Partner with us and reach a targeted audience of science enthusiasts and professionals through our platform. Your company/institute’s banner could be here.